SCHEMBL8285709

SCHEMBL8285709

CC1=NS(=O)(=O)c2cc(Cl)ccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
CYP1A2 P05177 2/20 0.54
LMNA P02545 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
THRB P10828 1/20 0.54
TSHR P16473 1/20 0.54
ABCC8 Q09428 1/20 0.54
KCNJ11 Q14654 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CHEK1 O14757 1/20 0.40
DAPK3 O43293 1/20 0.40
MAP4K4 O95819 1/20 0.40
RET P07949 1/20 0.40
PIM1 P11309 1/20 0.40
LTK P29376 1/20 0.40
GRK5 P34947 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CDK8 P49336 1/20 0.40
PRKX P51817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285712 0.85 LMNA (0.50) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL8285723 0.81 GAA (0.42) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL10908011 0.81 ALDH1A1 (0.49) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL17927656 0.78 EPAS1 (0.38) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL11090203 0.77 ALDH1A1 (0.46) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL8285719 0.75 LMNA (0.44) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL8285731 0.75 PTGES (0.44) CYP1A2PTGESCA12CA2CA4
SCHEMBL8285720 0.75 ALOX5 (0.41) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL2796295 0.74 CHEK1 (0.44) ALDH1A1CYP1A2LMNACYP3A4CYP2D6
SCHEMBL8285736 0.74 CHEK1 (0.45) ALDH1A1SMN1; SMN2CHEK1CA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed